Insecticides (India) Reports Audited FY26 Results, Approves ESOP Scheme
Insecticides (India) Limited approved audited financial results for FY26. The company also formulated the 'IIL ESPS Scheme 2026', proposing up to 2,00,000 equity shares. Mrs. Nikunj Aggarwal resigned as Whole Time Director. Mr. Sanskar Aggarwal was appointed as Whole Time Director for five years. The 29th AGM is on August 12, 2026.
The approval of the ESOP scheme and changes in directorship and management positions are material events that can impact the company's governance and employee incentives. The release of audited financial results is also a standard but important disclosure.
The announcement includes routine financial results, approval of an ESOP scheme, and changes in directorship and management. While these are significant events, they do not present overwhelmingly positive or negative news. The financial results are presented without comparative commentary on performance trends in the provided text.
Insecticides (India) Limited announced the outcome of its Board Meeting held on May 28, 2026. The Board approved the Audited Financial Results for the Quarter and Year ended March 31, 2026, based on an unmodified opinion from its joint statutory auditors. The company also approved the formulation of the 'IIL ESPS Scheme 2026', allowing for the issuance of up to 2,00,000 equity shares, subject to shareholder approval at the upcoming 29th Annual General Meeting (AGM).
In personnel changes, the Board took note of the resignation of Mrs. Nikunj Aggarwal as Whole Time Director. Subsequently, Mr. Sanskar Aggarwal was appointed as Whole Time Director (Additional) for a term of five years, effective from May 28, 2026. Additionally, Mr. Atul Kumar was appointed as Vice President - Sales (North), a Senior Management Personnel, effective May 28, 2026. The Board also approved the appointment of M/s. T Jain & Associates as Internal Auditors for a five-year term starting April 1, 2026.
The 29th AGM of the Company is scheduled to be held on Wednesday, August 12, 2026, at 03:00 PM through Video Conferencing. The Board meeting commenced at 01:00 PM (IST) and concluded at 04:15 PM (IST).
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.